Concepedia

Rhamy Zeid

RZ

Statistics

Publications

15

Citations

3.8K

H-Index

14

Active since

2011

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Broad Institute

Boston Children's Hospital

Brigham and Women's Hospital

Rhamy Zeid is an author at Dana-Farber Cancer Institute specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2011–2022

15

Publications

15

Melanoma genome sequencing reveals frequent PREX2 mutations

Michael F. Berger, Eran Hodis, Timothy P. Heffernan et al. · Nature · 2012 · 759 citations · Full text

Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe et al. · Cancer Discovery · 2013 · 624 citations · Full text

, , +14

BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment

Georg Winter, Andreas Mayer, Dennis L. Buckley et al. · Molecular Cell · 2017 · 467 citations · Full text

, , +7

Active medulloblastoma enhancers reveal subgroup-specific cellular origins

Charles Y. Lin, Serap Erkek, Yiai Tong et al. · Nature · 2016 · 390 citations · Full text

, , +4

BET Bromodomain Inhibition of <i>MYC</i> -Amplified Medulloblastoma

Pratiti Bandopadhayay, Guillaume Bergthold, Brian T. Nguyen et al. · Clinical Cancer Research · 2013 · 341 citations · Full text

1–5 of 15